Juvenile Dermatomyositis Clinical Trial
Official title:
Retrospective Descriptive Study of Juvenile Dermatomyositis in Alsace
This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.
Status | Recruiting |
Enrollment | 22 |
Est. completion date | January 2019 |
Est. primary completion date | January 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A to 16 Years |
Eligibility |
Inclusion Criteria: - Age under 16 years - Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975 Exclusion Criteria: - Refusal to participate in the study |
Country | Name | City | State |
---|---|---|---|
France | Service de Dermatologie | Strasbourg |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Strasbourg, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Study of clinical characteristics of juvenile dermatomyositis | The period from from January 1st, 2000 to December 31st, 2015 will be examined |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Recruiting |
NCT05524311 -
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
|
Phase 2 | |
Recruiting |
NCT00059748 -
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
|
||
Completed |
NCT00323960 -
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
|
Phase 3 | |
Completed |
NCT02267005 -
The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
|
N/A | |
Completed |
NCT00106184 -
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
|
Phase 2 | |
Completed |
NCT02245841 -
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
|
Phase 4 | |
Completed |
NCT03430388 -
Yellow Fever Vaccine in Patients With Rheumatic Diseases
|
N/A | |
Recruiting |
NCT01217320 -
Creatine Supplementation in Pediatric Rheumatology
|
N/A | |
Completed |
NCT05509140 -
Clinical Analysis of Juvenile Dermatomyositis Patients
|
||
Recruiting |
NCT01276470 -
Environmental Risk Factors for the Anti-synthetase Syndrome
|
||
Recruiting |
NCT03432455 -
Incidence and Prevalence of Juvenile Dermatomyositis
|
N/A | |
Completed |
NCT00815282 -
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
|
Phase 4 | |
Completed |
NCT01697254 -
The CARRA Registry
|
N/A |